Evidence map›Paper›PMID 29912906›Full record

Trial reportPloS one2018

High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda.

Evelyne Kestelyn, Jennifer Ilo Van Nuil, Marie Michelle Umulisa, Grace Umutoni, Alice Uwingabire, Lambert Mwambarangwe, Mireille Uwineza, Stephen Agaba, Tania Crucitti, Janneke van de Wijgert and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Use of simulated vaginal and menstrual fluids to modelInternational journal of pharmaceutics: X · 2021
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Evelyne KestelynRinda Ubuzima, Kigali, Rwanda.ORCID 0000-0002-5728-0918
Jennifer Ilo Van NuilRinda Ubuzima, Kigali, Rwanda.
Marie Michelle UmulisaRinda Ubuzima, Kigali, Rwanda.
Grace UmutoniRinda Ubuzima, Kigali, Rwanda.
Alice UwingabireRinda Ubuzima, Kigali, Rwanda.
Lambert MwambarangweRinda Ubuzima, Kigali, Rwanda.
Mireille UwinezaRinda Ubuzima, Kigali, Rwanda.
Stephen AgabaRinda Ubuzima, Kigali, Rwanda.
Tania CrucittiInstitute of Tropical Medicine, Antwerp, Belgium.
Janneke van de WijgertUniversity of Liverpool, Institute of Infection and Global Health, Liverpool, United kingdom.
Thérèse DelvauxInstitute of Tropical Medicine, Antwerp, Belgium.
Ring Plus Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntroduction of contraceptive vaginal rings (CVRs) could expand the contraceptive method mix reducing the unmet need for family planning in Rwanda, but data on acceptability of CVRs from low and middle-income countries are lacking.

methodsThis study explores acceptability of contraceptive vaginal ring (NuvaRing) use in Kigali, Rwanda using a mixed methods approach. We collected quantitative and qualitative data before, during and after conducting a clinical trial, using Case Report Forms, Interviewer Administered Questionnaires, In Depth Interviews and Focus Group Discussions. We analyzed the data using an existing theoretical framework including product attributes, relationship attributes and sexual encounter attributes as well as the contextual environment.

resultsOur data showed that initial worries reduced over time with actual ring use and ring insertions and removals were described as easy. Most women did not feel the ring during daily activities, appreciated the lack of perceived negative side effects and the increased lubrication. Relationship attributes and sexual encounter attributes such as sexual comfort played a significant role in ring acceptability of the participants and their partners. The contextual environment including Rwandan cultural norms around sexuality positively influenced the acceptance of the NuvaRing. Overall satisfaction was high.

conclusionsAcceptability of the Nuvaring was high among study participants and represents a promising option that could contribute to lowering the unmet need for family planning in Rwanda.

Indexed as

Contraceptive Devices, FemaleAdultContraception BehaviorDeveloping CountriesFemaleFocus GroupsHumansInterviews as TopicPatient Acceptance of Health CareRwandaSurveys and Questionnaires

Identifiers

PMID29912906
PMCPMC6005526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.